Stay updated on Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial

Sign up to get notified when there's something new on the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page

  1. Check
    3 days ago
    No Change Detected
  2. Check
    11 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.0%
    Check dated 2026-03-06T18:31:16.000Z thumbnail image
  3. Check
    17 days ago
    No Change Detected
  4. Check
    32 days ago
    Change Detected
    Summary
    Revision label updated from v3.4.1 to v3.4.2. No substantive changes to study content or page behavior were observed.
    Difference
    0.0%
    Check dated 2026-02-13T12:31:23.000Z thumbnail image
  5. Check
    39 days ago
    Change Detected
    Summary
    The page now displays a minor version update from Revision: v3.4.0 to v3.4.1, with no visible changes to core content or user-facing features. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-02-05T23:13:22.000Z thumbnail image
  6. Check
    54 days ago
    Change Detected
    Summary
    A new 'Last Update Posted' label appears in the Study Record Dates section, and 'Last Update Posted (Estimated)' is removed.
    Difference
    0.0%
    Check dated 2026-01-22T09:34:32.000Z thumbnail image
  7. Check
    61 days ago
    Change Detected
    Summary
    The changes show a minor revision update from v3.3.3 to v3.3.4; no substantive study details appear affected. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2026-01-15T05:01:07.000Z thumbnail image
  8. Check
    82 days ago
    Change Detected
    Summary
    Locations section updated to add Lower Saxony as a trial site, expanding available locations. The page also removes the Lower Saxony Locations entry and the HHS Vulnerability Disclosure reference from the footer area.
    Difference
    0.2%
    Check dated 2025-12-24T23:11:55.000Z thumbnail image

Stay in the know with updates to Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Nivolumab Plus Ipilimumab vs. Standard of Care Clinical Trial page.